Zymeworks
Computational biotechnology company that is focused on optimizing therapeutic antibodies and other protein-based therapeutics. Learn more
Launch date
Employees
Market cap
CAD1.2b
Enterprise valuation
CAD792m (Public information from Sep 2024)
Share price
$12.52 ZYME
Vancouver British Columbia (HQ)
Authorizing premium user...